The IVD Working Group is a specialised group that focuses on issues related to in-vitro diagnostics (IVD) across key areas such as regulatory affairs, market access, and government affairs and policy. The working group is composed of representatives from various IVD member companies and experts in the field who collaborate to tackle industry challenges, advocate for supportive policies, and ensure that IVD products are both accessible and meet rigorous regulatory standards.
Company Representation
Objectives of the In Vitro Diagnostics Working Group:
Emphasise the importance of diagnostics in healthcare and work towards driving better patient access to diagnostics in the Asia Pacific Region.
Current Projects:
Strengthen the Role of Diagnostics in Public Health Collaborate with local governments to advance the implementation of World Health Assembly Resolution on Diagnostics in APAC.
Facilitate a Standardised and Clear Regulatory Framework For IVD Develop a landscape to highlight both the alignments and the divergent practices on LDTs regulations across the globe.
Unlock the Value of Next Generation Sequencing Advancing patient access to NGS technologies for cancer care in the region.